INOVIO PHARMACEUTICALS, INC. Available-for-sale Securities
INOVIO PHARMACEUTICALS, INC. (INO) had Available-for-sale Securities of $105.96 million as of 2017-12-31, per its 10-K filed 2019-03-12.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2019-03-12
- 2017-12-31: Available-for-sale Securities $105.96M.
- 2017-09-30: Available-for-sale Securities $121.33M.
- 2017-06-30: Available-for-sale Securities $71.48M.
- 2017-03-31: Available-for-sale Securities $69.78M.
| Period end | Available-for-sale Securities |
|---|---|
| 2017-12-31 | $105.96M 10-K · filed 2019-03-12 |
| 2017-09-30 | $121.33M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $71.48M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $69.78M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $89.41M 10-K · filed 2018-03-14 |
| 2016-09-30 | $100.97M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $111.39M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $110.19M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $110.40M 10-K · filed 2017-03-15 |
| 2015-09-30 | $92.44M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $84.30M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $54.87M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $53.08M 10-K · filed 2016-03-14 |
| 2014-09-30 | $30.26M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $20.32M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $18.01M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $18.91M 10-K · filed 2015-03-16 |
| 2013-09-30 | $13.10M 10-Q · filed 2013-11-12 |
| 2012-12-31 | $8.03M 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |